[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

10X Genomics Inc (TXG)

10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,412,356
  • Shares Outstanding, K 126,956
  • Annual Sales, $ 642,820 K
  • Annual Income, $ -43,540 K
  • EBIT $ -39 M
  • EBITDA $ 5 M
  • 60-Month Beta 2.12
  • Price/Sales 6.35
  • Price/Cash Flow N/A
  • Price/Book 4.69

Options Overview Details

View History
  • Implied Volatility 87.77% (+4.20%)
  • Historical Volatility 71.21%
  • IV Percentile 75%
  • IV Rank 59.50%
  • IV High 112.74% on 11/19/25
  • IV Low 51.09% on 08/21/25
  • Expected Move (DTE 28) 5.13 (14.75%)
  • Put/Call Vol Ratio 0.09
  • Today's Volume 1,641
  • Volume Avg (30-Day) 1,273
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 13,305
  • Open Int (30-Day) 10,302
  • Expected Range 29.63 to 39.89

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.23
  • Number of Estimates 6
  • High Estimate $-0.18
  • Low Estimate $-0.30
  • Prior Year $0.28
  • Growth Rate Est. (year over year) -182.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.88 +66.45%
on 05/19/26
35.65 -2.50%
on 06/04/26
+13.31 (+62.03%)
since 05/18/26
3-Month
16.85 +106.26%
on 03/19/26
35.65 -2.50%
on 06/04/26
+17.41 (+100.32%)
since 03/18/26
52-Week
10.48 +231.63%
on 06/23/25
35.65 -2.50%
on 06/04/26
+23.89 (+219.73%)
since 06/18/25

Most Recent Stories

More News
10x Genomics (TXG): Buy, Sell, or Hold Post Q1 Earnings?

10x Genomics (TXG): Buy, Sell, or Hold Post Q1 Earnings?

TXG : 34.76 (+8.17%)
10x Genomics and Cleveland Clinic Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies in Patients with Bladder Cancer

Collaboration aims to identify biomarkers predictive of antibody-drug conjugate (ADC) treatment response using 10x's single cell and spatial platforms

TXG : 34.76 (+8.17%)
3 Small-Cap Stocks with Questionable Fundamentals

3 Small-Cap Stocks with Questionable Fundamentals

TXG : 34.76 (+8.17%)
VRNS : 33.38 (+0.91%)
FUBO : 9.22 (+3.60%)
10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group

Acquisition Expands 10x Genomics' Capabilities in Proteomics

TXG : 34.76 (+8.17%)
The 5 Most Interesting Analyst Questions From 10x Genomics’s Q1 Earnings Call

The 5 Most Interesting Analyst Questions From 10x Genomics’s Q1 Earnings Call

TXG : 34.76 (+8.17%)
1 Cash-Producing Stock on Our Watchlist and 2 We Question

1 Cash-Producing Stock on Our Watchlist and 2 We Question

TXG : 34.76 (+8.17%)
ETSY : 73.95 (+1.54%)
TILE : 32.56 (+5.27%)
10x Genomics Q1 Earnings Call Highlights

10x Genomics (NASDAQ:TXG) reported a first-quarter revenue increase excluding prior-year settlement revenue and used its earnings call to emphasize the launch of Atera, a new spatial biology instrument...

TXG : 34.76 (+8.17%)
Why 10x Genomics (TXG) Stock Is Down Today

Why 10x Genomics (TXG) Stock Is Down Today

TXG : 34.76 (+8.17%)
TXG Q1 Deep Dive: Atara Launch, Spatial Platform Transition, and AI-Driven Demand

TXG Q1 Deep Dive: Atara Launch, Spatial Platform Transition, and AI-Driven Demand

TXG : 34.76 (+8.17%)
10x Genomics: Q1 Earnings Snapshot

10x Genomics: Q1 Earnings Snapshot

TXG : 34.76 (+8.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 70%. The market has entered overbought territory.

See More Share

Business Summary

10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.

See More

Key Turning Points

3rd Resistance Point 38.80
2nd Resistance Point 37.22
1st Resistance Point 35.99
Last Price 34.76
1st Support Level 33.18
2nd Support Level 31.60
3rd Support Level 30.37

See More

52-Week High 35.65
Last Price 34.76
Fibonacci 61.8% 26.03
Fibonacci 50% 23.06
Fibonacci 38.2% 20.09
52-Week Low 10.48

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.